IPO

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

New mid-tier producer Hemlo Mining Corp. celebrates its first gold pour at the historic Hemlo mine, signaling a seamless transition on record gold prices.

Belgian metals giant Campine invests in advanced antimony recycling and moves to continuous trading, navigating a volatile market with record-breaking earnings.

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.

Vision Marine secures critical funds for its electric boat ambitions, but the deal's terms raise questions about shareholder value and its financial health.

New Measure A funds will provide emergency rental aid to thousands of at-risk households, marking a major step in the county's new housing strategy.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.

With a pivotal FDA date set for June 2026, Achieve Life Sciences heads to the J.P. Morgan conference to discuss its promising anti-smoking drug.

Early Phase 1a data for Kalaris's new nAMD drug shows significant vision improvement and potential for extended durability, aiming to reduce patient burden.

Iconic Ohio-based Donatos Pizza is coming to Houston, bringing its Edge to Edge® pies into one of America's most competitive pizza scenes.

YXT.com's $100M shelf registration gives it a war chest for AI growth, but investors weigh the promise of innovation against current financial pressures.

A key trial update de-risks Tenax Therapeutics' pivotal study for a novel heart failure therapy, boosting confidence in its path to market.

Amid a booming uranium market, Stallion Uranium has increased its private placement to over $6M, signaling strong investor confidence in Athabasca Basin exploration.

Backed by Google, a massive AI data center lease transforms Hut 8 and promises a generational economic windfall for Louisiana in the AI arms race.

Swedish crypto firm Virtune extends its deal with table tennis champ Truls Möregårdh, a move signaling a strategy to win mainstream trust in a regulated Europe.

With a reverse stock split, Idaho Copper is making a bold play for the NYSE to unlock capital for its world-class copper and molybdenum deposit.

Can-Fite BioPharma eyes key 2026 data readouts for its late-stage oral drugs targeting advanced liver cancer, psoriasis, and other unmet medical needs.

The Nasdaq-listed restaurant operator confirms its board and auditor, signaling stability as it navigates a volatile stock performance and dynamic F&B sector.

The iGaming supplier launches 80 exclusive games in Brazil's new regulated market, a strategic move to capture growth in Latin America's largest economy.

Riding a wave of record sales from its iDose TR implant, Glaukos is set to update investors on its explosive growth and the launch of its new drug, Epioxa.